Answers are grounded in this paper and cite their sources.
Case series reveals severe hemolytic anemia in families with triosephosphate isomerase deficiency, suggesting genetic implications.
Triosephosphate isomerase deficiency (TPID) is the most severe glycolytic enzyme defect associated with a progressive neurologic dysfunction. It typically causes hemolytic anemia, neurodegeneration, and recurrent bacterial infections. TPID is caused by a homozygous or a compound heterozygous mutation in the TPID gene. The most frequent variant is Glu104Asp. We report a case series from three unrelated Tunisian families affected by TPID caused by a homozygous Glu104Asp mutation. These reported cases had severe hemolytic anemia. Informed consent was obtained from patients’ parents.
No takes yet. Share an insight, caveat, or question.
ELLEUCH et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: